U.S. Critical Care Antibiotics Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

The U.S. Critical Care Antibiotics Markets report covers the various injectable antibiotics that are currently available and used in critical care in the U.S. namely, cephalosporins, quinolones, penicilliins, carbapenems and others including new classes streptogrammins and oxazolidones. The report also major pipeline critical care antibiotics. Frost & Sullivan Market Engineering Analysis, major market/technology trends, challenges, drivers and restraints and forecasts are covered on a total level and also as at the levels of the various segments. The report cites five prestigious Frost & Sullivan Market Engineering Awards to active industry participants for effective industry approaches.

Table of Contents

U.S. Critical Care Antibiotics Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Critical Care Antibiotics Markets, Total Critical Care Antibiotics MarketsDefinitions and ClassificationReport ScopeInfections in Critical Care SettingsAntibiotics as Life-Sustaining TechnologyCritical Care AntibioticsChallengesExpanding Resistant StrainsMore Stringent Treatment GuidelinesIncreasing Communication ResponsibilitiesMarket DynamicsMarket TrendsMarket DriversMarket RestraintsPricing AnalysisDemand AnalysisRevenue ForecastsCompetitive AnalysisMarketing Engineering AnalysisCompetitive StructureMarket Engineering AwardsBusiness Development Strategy AwardBrand Awareness Development AwardProduct Innovation Strategy AwardProduct Line Strategy AwardTechnology Innovation AwardU.S. Critical Care Antibiotics Markets, Critical Care Cephalosporins MarketMarket OverviewCritical Care CephalosporinsProduct AnalysisPricing AnalysisRevenue ForecastsCompetitive AnalysisMarket Engineering AnalysisCompetitive StructureU.S. Critical Care Antibiotics Markets, Critical Care Quinolones MarketMarket OverviewCritical Care QuinolonesProduct AnalysisPricing AnalysisRevenue ForecastsCompetitive AnalysisMarket Engineering AnalysisCompetitive StructureU.S. Critical Care Antibiotics Markets, Critical Care Penicillins MarketMarket OverviewCritical Care PenicillinsProduct AnalysisPricing AnalysisRevenue ForecastsCompetitive AnalysisMarket Engineering AnalysisCompetitive StructureU.S. Critical Care Antibiotics Markets, Critical Care Carbapenems MarketMarket OverviewCritical Care CarbapenemsPricing AnalysisRevenue ForecastsCompetitive AnalysisMarket Engineering AnalysisCompetitive StructureU.S. Critical Care Antibiotics Markets, Other Critical Care Antibiotics MarketMarket OverviewOther Critical Care AntibioticsStreptogramins and OxazolidonesMacrolides and LincosamidesGlycopeptides Tetracyclines and AminoglycosidesPricing AnalysisRevenue ForecastsCompetitive AnalysisMarket Engineering AnalysisCompetitive Structure




Related Research

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Release Date : 22-Aug-17

Region : North America

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.